Related Experiment Video
Updated: Jun 8, 2026
06:12
Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
Applicability of the FISH test for bladder cancer
Peggy Ward-Smith1, Brenda Miller, Michael Caughron
1University of Missouri, School of Nursing, Kansas City, MO USA.
Urologic Nursing
|October 19, 2010
Abstract
None:
Fluorescence in situ hybridization (FISH) analysis is an FDA-approved, urine-based marker that assists in diagnosis and surveillance of invasive urothelial cancer. This article provides an overview and case study demonstrating the clinical use of this analysis. As a systematic review of non-randomized and randomized clinical trials, this article provides Level I evidence.
